Microsoft word - uk at bio-europe.doc

UK Group (Booth #70B) Lead: Lin Bateson, BioPartner.co.uk http://www.biopartner.co.uk Mobile: +44 7734 933 464 Email: [email protected] COMPANY ABsynth Biologics is exploiting genomics Contact: Dr Fiona Marston, Chief Executive therapeutic antibodies for the prevention Alacrita provides the following services: professionalism and real-world relevance. Permanent or ‘Virtual’ Tenancies offered Contact: Mr William Sprigings, Marketing Director office space in the ‘Golden Triangle’ 40 provision of bio-decontamination systems Dr Richard Lucas, Biopharmaceutical Process applications. Unique patented hydrogen peroxide vapour (HPV) Contact: Mr Kassim Kolia, Business Development biopharmaceutical & vaccine contract Mr David Simpson, Process Development Manager and cGMP manufacturing. Offering a full range of services for biopharmaceuticals & vaccines, including: cell line/strain development & banking, process & analytical development & cGMP manufacturing for all significant biopharmaceutical product technologies. Contact: Dr Julie Wallis, Business Development commercialising its expertise in epithelial gastrointestinal diseases and dermatology. Epistem’s Contract Research Division has a track record of providing bespoke preclinical efficacy testing services to over 100 international clients in biotechnology, pharmaceutical and personal care sectors. Contact: Mr Mark Hopkins, Business Development clinical trial phase of drug development. outsourced synthesis and R&D from the pharmaceuticals, life sciences and fine chemicals. compounds from mushroom fermentations, either through collaboration with pharma companies, or by proprietary research e.g. Hypha's pipeline of anticancer compounds Contact: Mrs Lindsay Best, Associate Director, Contact: Dr Richard Broadhead, Technical Sales products, services, consultancy and training. All work related to our Services offering. Contact: Mr Michael Kruidenier, Business Contract Manufacturing, Qualified Persons Release Services, Paediatrics Formulation and Manufacturing, Hi-Potency capabilities, Orphan drug expertise’ More then 30 Years of specials, manufacturing expertise, Comparator Sourcing. The above offerings are all under one roof providing a strong and easy communication channel between departments making developments, manufacturing and analytical processes highly efficient world offering direct assessment of brain penetrability and free concentration of compounds in ECF using microdialysis NeuroPK®. Out-licensing of pre-clinical candidates Selcia Discovery, with a track record of Contact: Mr Dave Roberts, Business Development delivering robust clinical candidates, and Selcia Radiolabelling, a world leader in C- Contact:Mr Philip Kendall, Senior Sector Manager Other UK companies attending BIO-Europe: For more than 100 years, people around the world have looked to 3M for products and ideas that solve problems and make their lives easier and better. With a staff of 400 laboratory experts, ACM is able to offer a broad and customized menu of safety and specialty tests for clinical trials. Arrow Therapeutics, a fully-owned subsidiary of AstraZeneca, is a London-based pharmaceutical company, focused exclusively on the discovery and development of anti-viral small molecule therapeutics. BigDNA Ltd. is a vaccine development company, based at the Roslin BioCentre, Edinburgh, Scotland. The Company has developed a number of therapeutic and prophylactic vaccine candidates to target Hepatitis B, Chlamydia Biocompatibles International plc is a leading medical technology company in the field of drug-device combination products. Biocopea is a privately owned drug discovery company with a novel coherent approach to the development of treatments for respiratory disease. Bradford Pharma is an early stage drug discovery and development company Since 1982 Britannia has marketed branded niche products in UK secondary care therapy areas, some also requiring primary care reach. In addition we have outlicensed products to partners in 25 countries across 5 contintents. Cambridge Consultants is a leading technology and innovation company, renowned for its ability to solve technical problems and provide creative, practical solutions to business issues. CRT sources, develops and commercialises new cancer therapeutics, vaccines, diagnostics and enabling technologies. The company's strategy is focused on both the discovery and clinical stages of the pharmaceutical development process. Conformetrix is at the cutting edge of ligand-based drug discovery. Our proprietary analytical tools allow us to design NCEs using the body's own peptide hormones as high-specificity molecular templates. Coulter Partners is an executive search firm specialising in senior level executive and non-executive recruitment for the life science, healthcare and related sectors. Diamond provides high quality Regulatory, Pharmacovigilance and Compliance support and consulting services to the Biotech and Pharma industry, providing expertise to EU and non-EU companies Domainex has an internal pipeline of oncology targets which is based upon our unique technology Combinatorial Domain Hunting. These internal programmes are exclusively focussed on nucleotide triphosphate binding domains (NTP domains) Eisai is a global, Japanese Pharmaceutical company founded in 1941 with corporate head quarters in Tokyo, Japan. The company is currently ranked in the top 25 Pharmaceutical companies in the world with global sales of $7.8Bn in FY2008. Equateq specialises in the Research and Production of Pharmaceutical-grade Lipids. Our cGMP facility in Scotland has been operating for more than 20 years as a dedicated lipid development plant, and can deliver commercial quantities of whatever form. Evotec is engaged in the discovery and development of novel small molecule drugs and has established a powerful platform that is applicable to targets across all therapeutic areas with specific expertise in the area of central nervous system (CNS) The Ferghana Partners Group ("FPG") is an international provider of high level, independent corporate finance advice to firms in the pharmaceutical, biotechnology, chemical, medical device and diagnostics industries. Fulcrum Pharma is a professional service company providing clients with expert solutions for the development of therapeutic products. GlaxoSmithKline plc is a research-based pharmaceutical company. Company's mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Glide Pharma is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of biological medicines such as proteins and vaccines based on its unique Glide SDI® - the Glide Solid Dose Injector. Hospira is a global specialty pharmaceutical and medication delivery company. The company’s One 2 One® business is a world leader in the custom development and manufacture of parenteral products packaged in vials, prefilled syringes, and cartridges. IDIS are the industry experts in the design, implementation and management of medicine access programmes, including pre-launch named patient, compassionate supply programmes and specialist commercial supply. ImmuPharma PLC is a drug discovery and development company headquartered in London and listed on AiM. ImmuPharma has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). MPM is UK drug development company focussed exclusively on CNS products. The Nature Publishing Group (NPG) publishes quality research and review material; timely news; and essential career and recruitment information in science and clinical medicine. NPG combines the excellence of Nature, its associated primary research. NovaBiotics is a clinical stage anti-infectives company based in Aberdeen, UK. NovaBiotics' primary focus is the design and development of novel antifungal and antibacterial peptide therapeutics to address poorly met and economically signficant anti-infectives. NovaSecta is a London-based Consulting and Project Management company focused on smaller to mid-sized pharmaceutical and biotech companies. Novozymes Biopharma is a part of Novozymes A/S, the world leader in bioinnovation. Novozymes Biopharma is dedicated to the biopharmaceutical industry. With over 25 years of leadership in biomanufacturing and process development Oxford BioMedica is a biotechnology company specializing in the development of novel gene-based therapeutics for the treatment of cancer, neurodegenerative diseases and ocular disorders. Piramal Healthcare is a provider of high value-added integrated contract manufacturing solutions, providing best-in-class service at each stage of the value chain and across the product lifecycle of a pharmaceutical product prmaconsulting (www.prmaconsulting.com) offers best-in-class strategic and operational Pricing & Reimbursement, Market Access and Health Economics advice. We work for the majority of the top 15 Big Pharma companies, as well as the Biotech and Medtech. Proteome Sciences develops and applies integrated proteomics services based on its proprietary isobaric Tandem Mass Tag® technology for accurate and reliable quantification in mass spectrometry for biomarker discovery, validation and measurement. PsyRING, the Psychiatric Research Institute of Neuroscience in Glasgow, aims to add value to the psychiatric drug discovery process with focus on schizophrenia, to reduce the clinical failure of drug candidates by using novel translational models. Q Chip Ltd, incorporated in 2003, is a privately held Company based in Cardiff, UK. Q Chip’s proprietary Q-Sphera™ system is a proprietary technology for the development of sustained release biopharmaceuticals QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Essential & up-to-date articles on drugs in R&D development worldwide, compiled by an expert team of editors through interviews held at scientific and investor conferences, and updated weekly. Ruston Poole is a leading executive search consultancy, specialised exclusively in serving the management recruitment needs of the healthcare industry. Scancell is a listed UK Biotechnology company focussed on the development of novel DNA vaccines based on its proprietary ImmunoBody technology. Scottish Health Innovations Ltd (SHIL) provides Regulatory and Quality Assurance consultancy to the pharmaceutical and medical device industry. Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel medicines for the unmet needs of patients with rare diseases. Stabilitech has developed a novel proprietary technology which stabilizes live viral vaccines and biopharmaceuticals. For 38 years, Talentmark has focused on executive recruitment within the heathcare and life sciences industries. The Wellcome Trust is an independent charity funding research to improve human and animal health. Established in 1936 and with an endowment of around £12 billion, it is the UK's largest non-governmental source of funds for biomedical research. Ubichem provides a comprehensive range of chemistry services (on lab to pilot plant scale) to support early pharmaceutical development and meet your drug substance requirements. Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Its goal is to improve patients’ lives and generate value for stakeholders. Warwick Effect Polymers (WEP) is a polymer specialist company focusing in two main areas: biopolymers and speciality polymers. In biopolymers, WEP's leading technology is a novel, next generation PEGylation technology, called PolyPEG®. Wildwood Ventures Ltd is a company specializing in supporting corporate and business development in technology based companies. Xention Limited (“Xention”) is a life-science company focused on the discovery and clinical development of novel and selective ion channel-modulating drugs.

Source: http://www.biopartner.co.uk/documents/UK%20at%20BIO-Europe.pdf